Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) saw a significant drop in short interest in June. As of June 30th, there was short interest totalling 90,700 shares, a drop of 59.9% from the June 15th total of 226,200 shares. Based on an average daily trading volume, of 238,400 shares, the days-to-cover ratio is presently 0.4 days.
Coloplast A/S Trading Up 0.8 %
CLPBY traded up $0.10 during midday trading on Friday, hitting $12.84. The company had a trading volume of 56,512 shares, compared to its average volume of 174,875. Coloplast A/S has a twelve month low of $9.90 and a twelve month high of $14.34. The firm’s 50-day simple moving average is $12.26 and its 200-day simple moving average is $12.51. The company has a current ratio of 0.60, a quick ratio of 0.39 and a debt-to-equity ratio of 0.71.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.08 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.08. Coloplast A/S had a net margin of 19.45% and a return on equity of 36.74%. The business had revenue of $959.05 million during the quarter. On average, analysts forecast that Coloplast A/S will post 0.34 EPS for the current fiscal year.
Coloplast A/S Cuts Dividend
Coloplast A/S Company Profile
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments.
See Also
- Five stocks we like better than Coloplast A/S
- 5 Top Rated Dividend Stocks to Consider
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- What is the NASDAQ Stock Exchange?
- This Financial Stock’s Earnings Signal a Buying Opportunity
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.